United States Cetuximab Market Report 2016

Publisher Name :
Date: 02-Dec-2016
No. of pages: 98
Inquire Before Buying

Notes:

Sales, means the sales volume of Cetuximab

Revenue, means the sales value of Cetuximab

This report studies sales (consumption) of Cetuximab in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Sanofi SA (France)

- Wyeth (US)

- GlaxoSmithKline Plc (UK)

- Abbott Laboratories (USA)

- Pfizer Inc. (USA)

- Eli Lilly and Company (US)

- Merck & Co., Inc. (US)

- Warner Chilcott plc (Ireland)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Cetuximab in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Cetuximab Market Report 2016

Table of Contents
United States Cetuximab Market Report 2016
1 Cetuximab Overview
1.1 Product Overview and Scope of Cetuximab
1.2 Classification of Cetuximab
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Cetuximab
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Cetuximab (2011-2021)
1.4.1 United States Cetuximab Sales and Growth Rate (2011-2021)
1.4.2 United States Cetuximab Revenue and Growth Rate (2011-2021)
2 United States Cetuximab Competition by Manufacturers
2.1 United States Cetuximab Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Cetuximab Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Cetuximab Average Price by Manufactures (2015 and 2016)
2.4 Cetuximab Market Competitive Situation and Trends
2.4.1 Cetuximab Market Concentration Rate
2.4.2 Cetuximab Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Cetuximab Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Cetuximab Sales and Market Share by Type (2011-2016)
3.2 United States Cetuximab Revenue and Market Share by Type (2011-2016)
3.3 United States Cetuximab Price by Type (2011-2016)
3.4 United States Cetuximab Sales Growth Rate by Type (2011-2016)
4 United States Cetuximab Sales (Volume) by Application (2011-2016)
4.1 United States Cetuximab Sales and Market Share by Application (2011-2016)
4.2 United States Cetuximab Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Cetuximab Manufacturers Profiles/Analysis
5.1 Sanofi SA (France)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Cetuximab Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Sanofi SA (France) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Wyeth (US)
5.2.2 Cetuximab Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Wyeth (US) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc (UK)
5.3.2 Cetuximab Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 GlaxoSmithKline Plc (UK) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Abbott Laboratories (USA)
5.4.2 Cetuximab Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Abbott Laboratories (USA) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Pfizer Inc. (USA)
5.5.2 Cetuximab Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Pfizer Inc. (USA) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Eli Lilly and Company (US)
5.6.2 Cetuximab Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Eli Lilly and Company (US) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Merck & Co., Inc. (US)
5.7.2 Cetuximab Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Merck & Co., Inc. (US) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Warner Chilcott plc (Ireland)
5.8.2 Cetuximab Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Warner Chilcott plc (Ireland) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
6 Cetuximab Manufacturing Cost Analysis
6.1 Cetuximab Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Cetuximab
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Cetuximab Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Cetuximab Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Cetuximab Market Forecast (2016-2021)
10.1 United States Cetuximab Sales, Revenue Forecast (2016-2021)
10.2 United States Cetuximab Sales Forecast by Type (2016-2021)
10.3 United States Cetuximab Sales Forecast by Application (2016-2021)
10.4 Cetuximab Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Cetuximab
Table Classification of Cetuximab
Figure United States Sales Market Share of Cetuximab by Type in 2015
Table Application of Cetuximab
Figure United States Sales Market Share of Cetuximab by Application in 2015
Figure United States Cetuximab Sales and Growth Rate (2011-2021)
Figure United States Cetuximab Revenue and Growth Rate (2011-2021)
Table United States Cetuximab Sales of Key Manufacturers (2015 and 2016)
Table United States Cetuximab Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cetuximab Sales Share by Manufacturers
Figure 2016 Cetuximab Sales Share by Manufacturers
Table United States Cetuximab Revenue by Manufacturers (2015 and 2016)
Table United States Cetuximab Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cetuximab Revenue Share by Manufacturers
Table 2016 United States Cetuximab Revenue Share by Manufacturers
Table United States Market Cetuximab Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cetuximab Average Price of Key Manufacturers in 2015
Figure Cetuximab Market Share of Top 3 Manufacturers
Figure Cetuximab Market Share of Top 5 Manufacturers
Table United States Cetuximab Sales by Type (2011-2016)
Table United States Cetuximab Sales Share by Type (2011-2016)
Figure United States Cetuximab Sales Market Share by Type in 2015
Table United States Cetuximab Revenue and Market Share by Type (2011-2016)
Table United States Cetuximab Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cetuximab by Type (2011-2016)
Table United States Cetuximab Price by Type (2011-2016)
Figure United States Cetuximab Sales Growth Rate by Type (2011-2016)
Table United States Cetuximab Sales by Application (2011-2016)
Table United States Cetuximab Sales Market Share by Application (2011-2016)
Figure United States Cetuximab Sales Market Share by Application in 2015
Table United States Cetuximab Sales Growth Rate by Application (2011-2016)
Figure United States Cetuximab Sales Growth Rate by Application (2011-2016)
Table Sanofi SA (France) Basic Information List
Table Sanofi SA (France) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi SA (France) Cetuximab Sales Market Share (2011-2016)
Table Wyeth (US) Basic Information List
Table Wyeth (US) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Wyeth (US) Cetuximab Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) Cetuximab Sales Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories (USA) Cetuximab Sales Market Share (2011-2016)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Inc. (USA) Cetuximab Sales Market Share (2011-2016)
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company (US) Cetuximab Sales Market Share (2011-2016)
Table Merck & Co., Inc. (US) Basic Information List
Table Merck & Co., Inc. (US) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co., Inc. (US) Cetuximab Sales Market Share (2011-2016)
Table Warner Chilcott plc (Ireland) Basic Information List
Table Warner Chilcott plc (Ireland) Cetuximab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Warner Chilcott plc (Ireland) Cetuximab Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cetuximab
Figure Manufacturing Process Analysis of Cetuximab
Figure Cetuximab Industrial Chain Analysis
Table Raw Materials Sources of Cetuximab Major Manufacturers in 2015
Table Major Buyers of Cetuximab
Table Distributors/Traders List
Figure United States Cetuximab Production and Growth Rate Forecast (2016-2021)
Figure United States Cetuximab Revenue and Growth Rate Forecast (2016-2021)
Table United States Cetuximab Production Forecast by Type (2016-2021)
Table United States Cetuximab Consumption Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting&hellip
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and&hellip
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries,&hellip
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the&hellip
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The&hellip
  • Global and United States Bacillus Subtilis Depth Research Report 2017-2022
    Published: 26-Jul-2017        Price: US 3190 Onwards        Pages: 108
    This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Depth Research Report, it covers all details inside analysis and opinion in Bacillus Subtilis industry. This report focus United States market, it covers details players regions product type and other details as following: Major Companies - Bayer (Germany) - BASF (Germany) - Tonglu Huifeng (C......
  • Global Arthroscopy Shaver Market Research Report 2017
    Published: 25-Jul-2017        Price: US 2900 Onwards        Pages: 111
    In this report, the global Arthroscopy Shaver market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Arthroscopy Shaver in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China ......
  • Global Baby Warm Scales Market Research Report 2017
    Published: 25-Jul-2017        Price: US 2900 Onwards        Pages: 104
    In this report, the global Baby Warm Scales market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Baby Warm Scales in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - J......
  • Asia-Pacific Mice Models Market Report 2017
    Published: 25-Jul-2017        Price: US 4000 Onwards        Pages: 113
    In this report, the Asia-Pacific Mice Models market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Mice Models for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan......
  • Global Oral Vaccine Market Research Report 2017
    Published: 25-Jul-2017        Price: US 2900 Onwards        Pages: 113
    In this report, the global Oral Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Oral Vaccine in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • Global Tuberculosis Drugs Market Size, Status and Forecast 2022
    Published: 25-Jul-2017        Price: US 3300 Onwards        Pages: 106
    This report studies the global Tuberculosis Drugs market, analyzes and researches the Tuberculosis Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Sanofi - Pfizer - Janssen Products - Otsuka - AstraZeneca - Lupin Pharmaceuticals - Akorn - STI Pharma - Sandoz - Labatec Pharma SA - Archivel Farma - Bi......
  • United States Nanopartiele Drug Delivery System (NDDS) Market Report 2017
    Published: 25-Jul-2017        Price: US 3800 Onwards        Pages: 105
    In this report, the United States Nanopartiele Drug Delivery System (NDDS) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market ......
  • Global Chlorhexidine Sales Market Report 2017
    Published: 25-Jul-2017        Price: US 4000 Onwards        Pages: 116
    In this report, the global Chlorhexidine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Chlorhexidine for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - Sout......
  • Global Ubiquitin Enzymes Sales Market Report 2017
    Published: 25-Jul-2017        Price: US 4000 Onwards        Pages: 125
    In this report, the global Ubiquitin Enzymes market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Ubiquitin Enzymes for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs